Bioceramics Global Market Report 2024

The bioceramics market size has grown strongly in recent years. It will grow from $3.87 billion in 2023 to $4.14 billion in 2024 at a compound annual growth rate (CAGR) of 7%. The growth observed in the historical period can be attributed to factors such as the increasing aging population, a rising incidence of chronic diseases, the demand for aesthetic dentistry, regulatory approvals and standards, and an increased focus on regenerative medicine.

The bioceramics market size is expected to see strong growth in the next few years. It will grow to $5.37 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The anticipated growth in the forecast period can be attributed to the increasing demand for bioactive ceramics, the expanding applications in neurology, the growing awareness of dental health, international collaborations in medical research, and a focus on personalized medicine. Key trends expected in the forecast period include the emergence of advanced 3D printing techniques, the development of multifunctional bioceramic materials, the utilization of nanotechnology in bioceramic design, the introduction of antibacterial bioceramics, a focus on bioresorbable bioceramics for temporary implants, and advancements in bioceramic coatings for implants.

The anticipated growth of the bioceramics market is driven by the increasing prevalence of orthopedic and dental disorders. Orthopedic and dental disorders encompass conditions affecting the musculoskeletal system and oral health, respectively. Bioceramics, known for their biocompatibility and resemblance to natural bones and teeth, play a crucial role in addressing these disorders. They are extensively utilized in orthopedics for implantation purposes, including hip and knee joint replacements. Similarly, in dentistry, bioceramics find wide applications in various restorative procedures such as crowns, bridges, and dental implants. The prevalence of work-related musculoskeletal disorders and global cases of oral diseases underscores the significance of bioceramics in these medical domains, emphasizing their pivotal role in treating orthopedic and dental conditions.

The bioceramics market is poised for growth due to the increasing incidence of cardiovascular diseases. Cardiovascular diseases encompass various disorders affecting the heart and blood vessels, contributing to a significant global health burden. Bioceramics play a vital role in cardiovascular interventions, serving as implantable materials in medical devices such as artificial heart valves and stents. This application enhances biocompatibility and durability in cardiac interventions. The persistent rise in cardiovascular diseases, with millions affected globally, underscores the importance of bioceramics in advancing medical solutions for improved patient outcomes.

The bioceramics market faces challenges from stringent clinical and regulatory processes. The term refers to rigorous standards and procedures governing the development, testing, and approval of medical products. These stringent processes may pose obstacles in terms of prolonged development timelines, elevated development costs, and market accessibility challenges for the bioceramics industry. The authorization of innovative medications in 2023 by the US Food and Drug Administration (FDA), with a majority based on randomized clinical trial results, highlights the complexities and stringent nature of regulatory processes impacting the bioceramics market's growth trajectory.

Leading companies in the bioceramics market are introducing advanced materials such as LithaBone HA 480 to enhance bioceramic implants' performance and the quality of 3D-printed bone implants. LithaBone HA 480, a hydroxyapatite (HA) type, is designed for the production of patient-specific ceramic implants, offering improved wall thickness and enhanced geometric flexibility. The launch of this innovative material by Lithoz GmbH showcases the commitment to revolutionize bone implant manufacturing, making them more effective, affordable, and accessible for diverse medical applications such as bone grafts, dental implants, and orthopedic prostheses.

In July 2023, SHS Gesellschaft fur Beteiligungsmanagement mbH, a Germany-based independent private equity firm, successfully acquired a majority stake in CAM Bioceramics for an undisclosed sum. This strategic acquisition is geared toward fortifying and expanding SHS's presence in the realm of innovative calcium phosphate solutions within the medical industry. The move is anticipated to propel the company's growth and success in the burgeoning bioceramics market. CAM Bioceramics, headquartered in the Netherlands, specializes in the manufacturing of bioceramics for applications in the medical and healthcare sectors.

Major companies operating in the bioceramics market report are Stryker Corporation, Kyocera Corporation, The Royal DSM Company, Zimmer-Biomet Holdings Inc., Dentsply Sirona, NGK Spark Plug Co. Ltd., Straumann Group, Morgan Advanced Materials PLC, CoorsTek Medical, Carborundum Universal Ltd., Washington Mills Ceramics Corporation, Saint-Gobain Ceramics And Plastics Inc., H.C. Starck Ceramics GmbH, Nobel Biocare Holding AG, Ceram Tec, Nabertherm GmbH., Collagen Matrix Inc., DePuy Synthes Inc., CamBioceramics, Sagemax Bioceramics, Astro Met Inc., Bonesupport AB, Berkeley Advanced BioTypes Inc., Matexcel, Jyoti Ceramic Industries Pvt. Ltd., Doceram Medical Ceramics GmbH, Amedica Corporation, BIOMATCAN Ltd., CaP Biomaterials LLC, IJ Research Inc.

North America was the largest region in the bioceramics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioceramics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioceramics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Bioceramics represent a category of biomaterials composed of ceramic compounds, specifically engineered for applications in medical and healthcare settings, including the repair or replacement of damaged bone tissue, joints, and other organs.

The primary types of bioceramics include bioinert, bioactive, and bioresorbable. Bioinert characterizes materials or substances with minimal reactivity, and examples encompass aluminum oxide, zirconia, calcium phosphate, and others. These bioinert bioceramics find applications in various medical fields such as orthopedics, dental implants, biomedical applications, and more.

The bioceramics market research report is one of a series of new reports that provides bioceramics market statistics, including bioceramics industry global market size, regional shares, competitors with a bioceramics market share, detailed bioceramics market segments, market trends and opportunities, and any further data you may need to thrive in the bioceramics industry. This bioceramics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioceramics market consists of sales of bio-conductive ceramics, piezoelectric ceramics, radiopaque ceramics and composite bioceramics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.